Einstein Medical Center Philadelphia

Philadelphia Jury Returns $10 Million Verdict Against Albert Einstein Medical Center for Deadly Surgery

Retrieved on: 
Domenica, Maggio 12, 2024
Patient, Risk, Court of Common Pleas, Obesity, Prevalence, Einstein Medical Center Philadelphia, Hill, Tubing (recreation), Medicine, P.C, Multimedia, History, Nursing

PHILADELPHIA, May 12, 2024 /PRNewswire-PRWeb/ -- Philadelphia injury attorney Leonard Hill, founder of Hill & Associates, P.C., represented the estate of Ellen Breen, who died following a minimally invasive surgery that went wrong. Hill's colleague Susan Ayres also assisted in representing the plaintiffs.

Key Points: 
  • The jury awarded a $10 million verdict in favor of the plaintiff on February 13th.
  • The jury found that Ellen Breen's death following an operation at Albert Einstein Medical Center occurred as a result of the surgeon's negligence.
  • Defense lawyers for Albert Einstein Medical Center argued that it provided appropriate care and noted that Breen had a history of health issues and prior surgeries.
  • The case, captioned Scott v. Einstein Medical Center, was tried before Judge Craig Levin of the Philadelphia Court of Common Pleas.

Latus Launches with State-of-the-Art Gene Therapy Development Technologies, Two Lead Product Candidates, and an Initial $54 Million in Series A Financing

Retrieved on: 
Giovedì, Maggio 2, 2024
Biotechnology, Professional Services, Health, General Health, Pharmaceutical, Other Science, Research, Genetics, Science, Clinical Trials, Finance, Doctor of Philosophy, CNS, SVP, Translational medicine, MIT, Genzyme, Cochlea, Hereditary Disease Foundation, Harvard Medical School, Toxicity, HTT, Therapy, Merck, CLN2, Hospital, Safety, Biomedical Research, Samsung Biologics, CHOP, Samsung C&T Corporation, AAV, Koch Institute, Gene expression, Central nervous system, NHP, Program management, Cell, DSM-IV codes, Patient, Gene, Society, Einstein Medical Center Philadelphia, Annual general meeting, Massachusetts General Hospital, Pharmaceutical industry

Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.

Key Points: 
  • Latus Bio, Inc. (“Latus”), a biotechnology company developing novel gene therapy candidates for disorders of the central nervous system (CNS), today announced its launch and an initial close of $54 million in Series A financing.
  • These limitations have led to the reliance on high-dose injections that cause off-target toxicity and difficulties in scalable manufacturing.
  • The Company’s management team is composed of experienced and respected leaders in gene therapy and neuroscience.
  • Her address will showcase the Company's progress and the vast potential of its technology to solve unmet needs in CNS gene therapy.

Emergency Departments Frequently Miss Signs of Epilepsy in Children

Retrieved on: 
Mercoledì, Maggio 1, 2024
Roger Hawkins (drummer), University, Stroke, Seizure, Hospital, Risk, Death, DSM-IV codes, NYU Langone Health, Partnership, Doctor of Philosophy, Research, Emotion, NYU, History, Knowledge, Patient, Physician, Neurology, Epilepsy, Child, Diagnosis, Einstein Medical Center Philadelphia, Brain, Panic, Amnesia, Anxiety, Pharmaceutical industry

The work focuses on "nonmotor" seizures, which cause children to "zone out" and stare into space or fidget.

Key Points: 
  • The work focuses on "nonmotor" seizures, which cause children to "zone out" and stare into space or fidget.
  • To be diagnosed with the condition, a patient must have experienced a minimum of two seizures with no apparent cause.
  • Their analysis showed that emergency department physicians correctly identified only 33% of first-time nonmotor seizures, compared with 81% of first-time motor seizures.
  • According to the United States Centers for Disease Control and Prevention, epilepsy is one of the most common brain disorders in children, affecting 470,000 under age 17.

Citadel Credit Union Appoints New Members to its Board of Directors and Supervisory Committee

Retrieved on: 
Mercoledì, Maggio 1, 2024
Electrical engineering, Volunteering, Society, Sallie Mae, Central Waqf Council, Hospital, Bucks County, Pennsylvania, Marketing, SIM, Citadel Credit Union, Insurance, Schuler, Information management, CISSP, Gopal, Telehealth, QNB Bank, Drexel University, Independence Blue Cross, Communication, Einstein Medical Center Philadelphia, MBA, Commitment, Enterprise risk management, Management

EXTON, Pa., May 1, 2024 /PRNewswire/ -- Citadel Credit Union proudly announces the addition of two distinguished members to both its Board of Directors and Supervisory Committee, reflecting its ongoing commitment to strong governance, business evolution and community service.

Key Points: 
  • EXTON, Pa., May 1, 2024 /PRNewswire/ -- Citadel Credit Union proudly announces the addition of two distinguished members to both its Board of Directors and Supervisory Committee, reflecting its ongoing commitment to strong governance, business evolution and community service.
  • Jessica Schuler and Madhav Gopal have joined the credit union's Board of Directors, and Crystal Nguyen and Jennifer Frost have been appointed to the Supervisory Committee.
  • Madhav Gopal transitions to the Board of Directors following eight years on the Supervisory Committee.
  • Our Board of Directors and Supervisory Committee are unpaid volunteers dedicated to serving our member-owners rather than shareholders.

NAHQ Announces 2024 Board Members

Retrieved on: 
Lunedì, Aprile 8, 2024
Hospital, RN, Health, ChristianaCare, Health care, CHC, CAE, Patient safety, RNC-NIC, RRT, Lifespan, Safety, Workforce, National Association, MHA, Organization, Trinity Health, University, MJ, Senior, Nursing, Trinity, Einstein Medical Center Philadelphia, Trinity Health (Livonia, Michigan), Johns Hopkins Hospital, CPPS, Texas Children's Hospital, Doctor of Philosophy, MBA, Quality, Fesler

CHICAGO, April 8, 2024 /PRNewswire/ -- The National Association for Healthcare Quality® (NAHQ) has announced its new board members and leadership positions: Patricia Resnik, MJ, MBA, RRT, FACHE, CPHQ, CHC, CHPC, as its 2024 president; April M. Taylor, MS, MHA, FACHE, CMQ/OE, CLSSBB, CPHQ, CPPS, as president-elect; Cathy Duquette, PhD, MBA, RN, NEA-BC, CPHQ, FNAHQ, as secretary/treasurer; and Sheranda Fesler, PhD, RN, RNC-NIC, NE-BC, CPHQ, CPPS, FNAHQ, as chair of the individual strategic advisory council.

Key Points: 
  • "It is an honor to welcome these industry leaders as they step into their new roles on the board.
  • "It is my privilege to serve as the NAHQ president this year with such a distinguished group of quality colleagues," Resnik stated.
  • "As my work with NAHQ deepens each year, so does my affinity for and dedication to its purpose and vision.
  • "I am deeply honored to bring my experience, passion and commitment to healthcare quality and safety to my role on the NAHQ board," said Fesler.

Vanguard Announces CEO Retirement and Appointment of President

Retrieved on: 
Giovedì, Febbraio 29, 2024
Federal Reserve Bank, Pennsylvania State University, Trustee, Growth, Hospital, Retirement, ETF, Human, University, Market, Vanguard, History, COVID, Policy, Einstein Medical Center Philadelphia, CIO, Treasury, Research, Insurance, Management

Vanguard's Board of Directors has initiated a comprehensive process to select a new CEO, evaluating both internal and external candidates.

Key Points: 
  • Vanguard's Board of Directors has initiated a comprehensive process to select a new CEO, evaluating both internal and external candidates.
  • Vanguard also announced today that Chief Investment Officer Greg Davis has been appointed to the additional role of President of the firm, effective immediately.
  • Today, Vanguard is poised to seize the opportunities of the future while continuing to deliver for our investor-owners."
  • Mr. Davis, a 24-year Vanguard veteran, was first appointed CIO and global head of Vanguard Investment Management Group in 2017.

Freedom Mortgage Wraps Up a Solid 2023

Retrieved on: 
Lunedì, Gennaio 22, 2024
Dream, Freedom, Toys for Tots, Meal, Hunger, CHOP, Hospital, Social media, Partnership, Housing, Reservist, Children's Hospital of Philadelphia, Friends, Einstein Medical Center Philadelphia, United Service Organizations, Comment, Mortgage Bankers Association, Veteran, Freedom from Hunger, National Guard, Toy, FHA, Backpack, South China Sea raid, Hospice and palliative medicine, The Salvation Army, Feeding America, Federal Housing Administration, USO, Real estate

BOCA RATON, Fla., Jan. 22, 2024 /PRNewswire/ -- Freedom Mortgage, one of the largest full-service independent mortgage companies, and a top VA and top Federal Housing Administration (FHA) (government-insured) lender in the U.S., had a solid 2023, helping nearly 80,000 borrowers secure financing for their most important asset—their homes.

Key Points: 
  • Last year, Freedom Mortgage helped over 50,000 borrowers successfully achieve a better financial position through loan modifications or partial claims.
  • Middleman commended Freedom Mortgage employees for their generosity and dedication to supporting multiple charitable organizations throughout 2023, including programs for veterans, service members, and their families.
  • Additionally, through donations from entries in the Freedom Mortgage Celebrate Freedom Award contest and employees' payroll deduction, over $30,000 was raised for Feeding America.
  • One of the nation's largest independent mortgage companies, Freedom Mortgage is committed to fostering homeownership and financial betterment across the country.

Introducing Hockey Cares: Supporting Those in Need from the Delaware Valley Amateur Hockey Community

Retrieved on: 
Martedì, Gennaio 2, 2024
Associate, Injury, Quality of life, Hospital, Disability studies, CHOP, Hockey Central, Glacier, Brain damage, Trauma, Malvern Preparatory School, NHL, Abramson, New Hampshire College, AAHA, Rochester Institute of Technology, Holy Spirit in Christianity, Philadelphia Flyers, USA Hockey, Ice, Einstein Medical Center Philadelphia, Hockey, Sports equipment

PHILADELPHIA, Jan. 2, 2024 /PRNewswire/ -- The Hockey Cares Foundation, a Pennsylvania-qualified 501(c)(3) nonprofit, has launched Hockey Cares to support current and former ice hockey players and their families in the Delaware Valley amateur hockey community.

Key Points: 
  • PHILADELPHIA, Jan. 2, 2024 /PRNewswire/ -- The Hockey Cares Foundation, a Pennsylvania-qualified 501(c)(3) nonprofit, has launched Hockey Cares to support current and former ice hockey players and their families in the Delaware Valley amateur hockey community.
  • "Hockey Cares aims to ensure that no member of our hockey family faces financial hardships alone during their most challenging times."
  • Jacobs, a former Malvern Prep hockey player, brings market research and coaching expertise to the board, along with over 30 years of hockey involvement in the Delaware Valley.
  • For more information about Hockey Cares or to support its mission, visit the Hockey Cares website.

Vertex and CRISPR Therapeutics Announce US FDA Approval of CASGEVY™ (exagamglogene autotemcel) for the Treatment of Sickle Cell Disease

Retrieved on: 
Venerdì, Dicembre 8, 2023
FDA, Health, Stem Cells, Genetics, Pharmaceutical, Biotechnology, Einstein Medical Center Philadelphia, Food, Transplant, CRISPR Therapeutics, Therapy, Sickle cell disease, University of Chicago, Disease, Patient, Section, CRSP, Vertex Pharmaceuticals, The James Cancer Hospital, CRISPR, Committee, Volatile organic compound, Hospital, SCD, Haematopoietic system, Boston Medical Center, Pharmaceutical industry, Nursing, Vertex, Boston

Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).

Key Points: 
  • Vertex Pharmaceuticals Incorporated (Nasdaq: VRTX) and CRISPR Therapeutics (Nasdaq: CRSP) announced today that the U.S. Food and Drug Administration (FDA) has approved CASGEVY™ (exagamglogene autotemcel [exa-cel]), a CRISPR/Cas9 genome-edited cell therapy, for the treatment of sickle cell disease (SCD) in patients 12 years and older with recurrent vaso-occlusive crises (VOCs).
  • “CASGEVY’s approval by the FDA is momentous: it is the first CRISPR-based gene-editing therapy to be approved in the U.S. As importantly, CASGEVY is a first-in-class treatment that offers the potential of a one-time transformative therapy for eligible patients with sickle cell disease,” said Reshma Kewalramani, M.D., Chief Executive Officer and President of Vertex.
  • So, this U.S. approval of the first-ever medicine using CRISPR gene editing is breathtaking, and a truly humbling moment for me personally and for the whole organization,” said Samarth Kulkarni, Ph.D., Chairman and Chief Executive Officer of CRISPR Therapeutics.
  • The following ATCs are already activated:
    Boston Medical Center in Boston, Mass.

Freedom Mortgage Corporation Launches Its Annual Holiday Toy Fundraising Campaign

Retrieved on: 
Mercoledì, Novembre 1, 2023
Federal Housing Administration, Holiday, Freedom Mortgage Pavilion, Toys for Tots, Freedom, Einstein Medical Center Philadelphia, FHA, Volunteering, CHOP, Philadelphia, Hospital, The Salvation Army, Toy, Veteran

BOCA RATON, Fla., Nov. 1, 2023 /PRNewswire/ -- Freedom Mortgage, one of the largest full-service independent mortgage companies, and a top VA and top Federal Housing Administration (FHA) (government-insured) lender in the U.S., launches its Holiday Toy Fundraising campaign today. The annual giving campaign encourages Freedom Mortgage's employees, business partners, customers and the general public to join its efforts in providing holiday gifts for less-fortunate children across the country.

Key Points: 
  • The annual giving campaign encourages Freedom Mortgage's employees, business partners, customers and the general public to join its efforts in providing holiday gifts for less-fortunate children across the country.
  • "During the holidays, it's especially important to look after those in need," said Stanley C. Middleman, Freedom Mortgage president and CEO.
  • For more than a decade, Freedom Mortgage's Holiday Toy campaign has provided thousands of toys each year—totaling nearly 63,000 toys to children across the country.
  • In December, Freedom Mortgage employees will once again volunteer at holiday toy distribution events at Salvation Army centers , which are always in need of volunteers.